Approval · Notice of Compliance 16109 · 2014
OLEX: Notice of Compliance 16109
Issued September 17, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16109
- Date
- September 17, 2014
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Therapeutic class
- H+,K+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OLEX | 02365677 | Cancelled Post Market |
Medicinal ingredients
- OMEPRAZOLE 20 MG per TAB